- Report
- February 2024
- 114 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 105 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 110 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 115 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 120 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 120 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Report
- April 2023
- 120 Pages
Global
From €4222EUR$4,750USD£3,664GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4445EUR$5,000USD£3,857GBP
- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2667EUR$3,000USD£2,314GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1778EUR$2,000USD£1,543GBP
- Report
- June 2024
- 200 Pages
Global
From €7067EUR$7,950USD£6,133GBP
- Report
- June 2024
- 200 Pages
Global
From €7067EUR$7,950USD£6,133GBP
- Report
- October 2022
- 200 Pages
Global
From €2622EUR$2,950USD£2,276GBP
- Report
- July 2023
- 115 Pages
Global
From €4000EUR$4,500USD£3,471GBP
- Report
- July 2023
- 113 Pages
Global
From €4000EUR$4,500USD£3,471GBP
- Report
- August 2024
- 200 Pages
Global
From €3439EUR$3,869USD£2,985GBP
- Report
- April 2023
- 147 Pages
Global
From €4399EUR$4,949USD£3,818GBP
- Report
- April 2023
- 147 Pages
Global
From €4399EUR$4,949USD£3,818GBP
- Report
- April 2023
- 147 Pages
Global
From €4399EUR$4,949USD£3,818GBP
- Report
- June 2025
- 250 Pages
Germany
From €2479EUR$2,789USD£2,152GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more